Australian Health Insurance Premiums Set for 25% Surge, CHOICE Warns

The Australian private health insurance sector is facing a potential crisis as consumer advocacy group CHOICE warns of premium hikes reaching as high as 25% for major funds. This projected increase is a staggering departure from the historical average of 2-4% seen over the last decade. For millions of Australians already grappling with high interest rates and inflation, a 25% jump in health insurance costs could be the breaking point that forces them to downgrade or cancel their coverage entirely.

This development places the Federal Health Minister in a difficult regulatory position. Traditionally, health funds submit their proposed premium increases to the Department of Health by late each year, with the Minister either approving or requesting a lower figure to balance fund sustainability with consumer affordability. A 25% request suggests that the underlying cost drivers—including medical technology, hospital utilization, and an aging population—have accelerated far beyond previous projections. It also reflects a post-pandemic correction where funds are seeing a surge in elective surgeries that were deferred during the COVID-19 era.

“

The Australian private health insurance sector is facing a potential crisis as consumer advocacy group CHOICE warns of premium hikes reaching as high as 25% for major funds.

The implications for the broader healthcare ecosystem are profound. If a significant portion of the 14 million Australians with private cover opts out, the burden will shift directly to the already strained public hospital system. This creates a "death spiral" effect: as healthier, younger members leave the private system to save money, the remaining pool of insured individuals becomes older and sicker, necessitating even higher premiums to cover their claims. This cycle undermines the government's policy of using private health insurance to alleviate pressure on Medicare.

Major industry players like Medibank and Bupa have yet to provide detailed justifications for such a steep increase, but industry analysts point to the rising cost of prosthetics and the increasing frequency of chronic disease management as primary factors. Furthermore, the private health insurance rebate—a government subsidy designed to make cover more affordable—has been steadily diluted over time as it is indexed to a lower rate than premium growth. This means consumers are paying a larger share of the total premium even before these new hikes are factored in.